This one almost slipped past me, except for the readers who e-mailed me to say "Hey--isn't that 'your' drug?"
Here's one article about the approval of T-DM1 to treat HER2-positive, late-stage breast cancer:
I've added more links below, and feel free to send along your own comments or links. This is an important drug.
Read about my battle to gain access to T-DM1 in a clinical trial here: T-DM1
Unfortunately, I had already been dropped from the trial because of disease progression before the drug was approved. Now, I don't know if it's worth asking my doctors about going back on T-DM1 as the better option of the treatments available to me .... I guess I'd better check in with Dr. Gralow.
The brand name is apparently Kadcyla--who can pronounce that?